Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
29
30
1
2
3
4
6
7
8
9
10
11
13
14
15
16
17
18
19
20
22
23
24
25
26
27
28
29
30
31
1
2
12:00 AM - NextGen UGM 2025
Pathology Visions 2025
2025-10-05 - 2025-10-07    
8:00 am - 5:00 pm
Elevate Patient Care: Discover the Power of DP & AI Pathology Visions unites 800+ digital pathology experts and peers tackling today's challenges and shaping tomorrow's [...]
AHIMA25  Conference
2025-10-12 - 2025-10-14    
9:00 am - 10:00 pm
Register for AHIMA25  Conference Today! HI professionals—Minneapolis is calling! Join us October 12-14 for AHIMA25 Conference, the must-attend HI event of the year. In a city known for its booming [...]
Federal EHR Annual Summit
2025-10-21 - 2025-10-23    
9:00 am - 10:00 pm
The Federal Electronic Health Record Modernization (FEHRM) office brings together clinical staff from the Department of Defense, Department of Veterans Affairs, Department of Homeland Security’s [...]
NextGen UGM 2025
2025-11-02 - 2025-11-05    
12:00 am
NextGen UGM 2025 is set to take place in Nashville, TN, from November 2 to 5 at the Gaylord Opryland Resort & Convention Center. This [...]
Events on 2025-10-05
Events on 2025-10-12
AHIMA25  Conference
12 Oct 25
Minnesota
Events on 2025-10-21
Events on 2025-11-02
NextGen UGM 2025
2 Nov 25
TN

Events

Press Releases

Qr8 Health™ announces the launch of PST Snapshot™ and Cognition Snapshot™

qr8 health

Qr8 Health, Inc a digital health company developing standardized, patient self-administered digital tests for the measurement of neurological and motor function announced today that is has launched two commercial FDA registered products, PST Snapshot™, a rapid digital cognitive function test that measures information processing speed and Cognition Snapshot™, a digital application that combines the PST (Processing Speed Test) with a test for visual memory (VMT). Processing speed and memory are often negatively affected in neurological disorders such as Alzheimer’s disease and Parkinson’s disease and are important to identify as they have the potential to be modified with cognitive training and future therapeutic interventions.

“We are pleased to make PST Snapshot and Cognition Snapshot commercially available as they enable a rapid and validated measurement of information processing speed and memory for use in clinical practice which traditionally has not had the time or resources to routinely measure cognitive function,” said Vincent Owens, Qr8 Health President and CEO, “We believe the ability to have regular, standardized cognitive assessments in everyday clinical practice will arm health care professionals with important information that will lead to interventions and improved patient outcomes”.

PST Snapshot is a validated digital application based on the symbol-digit modalities test (SDMT), a symbol substitution neuropsychological test that examines a person’s attention and speed of processing. Cognition Snapshot is a digital application that combines PST Snapshot with a visual memory test based upon the 7/24 Spatial Recall Test and has been designed and validated to measure episodic memory and delayed learning. These apps may be used where either processing speed, memory or both are affected by neurological conditions.

Unlike traditional neuropsychological tests which require a technician to administer and score them, PST Snapshot and Cognition Snapshot are patient self-administered. The results from both PST Snapshot and Cognition Snapshot are automatically scored and norm-adjusted, taking into account demographic variables including age and level of education.

PST Snapshot and Cognition Snapshot are the first of several neurological and motor assessments that Qr8 Health have in development.

About Qr8 Health
Qr8 Health, Inc is a digital health company developing standardized, validated, patient self-administered digital tests for the measurement of neurological and motor function along with patient reported outcomes that can be administered on a mobile tablet device and easily integrated into electronic health records. Founded in 2016, the company has been working to develop applications that quantitatively measure neurological and motor function which are often affected in many brain disorders but are not routinely assessed in clinical practice. For more information visit http://www.qr8health.com.

Contact Investors and Media:
David Blum
info@qr8health.com

Source